SQSTM1, a protective factor of SOD1-linked motor neuron disease, regulates the accumulation and distribution of ubiquitinated protein aggregates in neuron. (September 2022)

• Record Type: Journal Article
• Authors: Mitsui, Shun; Otomo, Asako; Sato, Kai; Ishiyama, Masahito; Shimakura, Kento; Okada-Yamaguchi, Chisa; Warabi, Eiji; Yanagawa, Toru; Aoki, Masashi; Shang, Hui-Fang; Hadano, Shinji
• Is Part Of: Neurochemistry international. Volume 158(2022)
• Publication Date: 2022-09
• Subjects: Amyotrophic lateral sclerosis -- Protein aggregation -- SQSTM1 -- SOD1 -- Ubiquitin; Neurochemistry -- Periodicals; Neurochemistry -- Periodicals; Neurochimie -- Périodiques; Neurochemistry; Periodicals; 612.804205
• DOI: 10.1016/j.neuint.2022.105364
• Languages: English
• ISSNs: 0197-0186

Abstract

Abstract: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by selective loss of motor neurons in the brain and spinal cord. Recent studies have shown that mutations in SQSTM1 are linked to ALS. It has also been demonstrated that a systemic loss of SQSTM1 exacerbates disease phenotypes in an ALS mouse model. However, it is still unclear whether and how SQSTM1 in the central nervous system (CNS) specifically regulates ALS-associated disease phenotypes. To address this issue, we generated CNS-specific Sqstm1 deficient SOD1 H46R transgenic mice, and conducted gross phenotype analyses as well as the immunohistochemical and biochemical examinations of spinal cord tissues using these mice. CNS-specific SQSTM1 deficiency accelerated the disease onset and shortened the lifespan of SOD1 H46R mice. The CNS-specific SQSTM1 ablation also resulted in increased number of ubiquitin-positive aggregates, while their size rather became much smaller. Remarkably, ubiquitin-positive aggregates, which were usually present in extracellular space and/or neuropil in SOD1 H46R mice, were preferentially localized to soma and neurites of spinal neurons in CNS-specific SQSTM1 deficient SOD1 H46R mice. Next, to further clarify the function of SQSTM1 in neurons, we investigated the contribution of SQSTM1 to the accumulation of polyubiquitinated proteins in relation to the ubiquitin proteasome system (UPS) and the autophagy-endolysosomal system (APELS) in primary cultured motor neurons (PMNs). Loss of SQSTM1 in PMNs resulted in decreased accumulation of insoluble polyubiquitinated proteins, which was induced by simultaneous treatment with proteasome and lysosome inhibitors, suggesting a pivotal role of SQSTM1 in the formation of insoluble protein aggregates. However, SQSTM1 silencing had a limited impact on the susceptibility to proteasome and/or lysosome inhibitor-induced apoptosis in PMNs. Taken together, neuronal SQSTM1, whose functions are associated with both the UPS and APELS, might primarily regulate the distribution and accumulation of misfolded protein aggregates in the CNS, thereby protecting neurons from degeneration in mice. Highlights: CNS-specific loss of SQSTM1 exacerbates the onset of ALS mice. SQSTM1 regulates the distribution of ubiquitin-positive aggregates in spinal cord. SQSTM1 facilitates the formation of insoluble polyubiquitinated proteins in cells. SQSTM1 has a limited impact on apoptosis in proteolytically-stressed neurons. SQSTM1 is implicated in the formation of disease protective protein aggregates.